Central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma
(DLBCL) carries a dismal prognosis and most clinical guidelines recommend CNS …

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma worldwide and
represents an increasingly heterogeneous entity [1, 2] as our understanding of the disease …

Progression or relapse in the central nervous system (CNS) remains a rare but mostly fatal
event for patients with diffuse large B-cell lymphoma (DLBCL). In a retrospective analysis of …

Primary testicular diffuse large B-cell lymphoma (PTL) is characterized by high risk of
contralateral testis and central nervous system (CNS) relapse. Chemoimmunotherapy with …

Summary This Good Practice Paper provides recommendations for the baseline
investigation, risk stratification and use of prophylactic interventions for patients with large B …

Little is known about the central nervous system (CNS) risk in high-grade B-cell lymphoma,
not otherwise specified (HGBL NOS). Hence, we sought to describe the rates of baseline …

Background Primary central nervous system lymphoma (CNSL) is a rare, aggressive non-
Hodgkin lymphoma confined to the CNS. Although radiation and chemotherapy, particularly …

Baseline characteristics and dosing in i-HD-MTX vs EOT groups were compared using
Chisquared tests and Wilcoxon Mann-Whitney tests. Linear regression was used to assess …

The use of central nervous system (CNS) prophylaxis for patients with diffuse large B-cell
lymphoma (DLBCL) remains controversial. Although uncommon, CNS relapses are …

Secondary CNS involvement (SCNSL) is a rare manifestation of diffuse large B-cell
lymphoma (DLBCL) with a poor prognosis. We present updated data from a nationwide …